Avigen's Gene Therapy Approach Shows Promise In Treating Hemophilia B With,,Single Intramuscular Administration

Long-Term Factor IX Expression and Improved Blood Clotting Time Achieved

SEATTLE, WASHINGTON (May 28, 1998): Scientists at Avigen, Inc. (Nasdaq: AVGN), and The Children's Hospital of Philadelphia have developed a gene therapy approach for the treatment of hemophilia B using a single intramuscular administration of an adeno-associated virus (AAV) vector containing the gene for coagulation factor IX. Katherine A. High, M.D., a hematologist at The Children's Hospital of Philadelphia and Avigen scientific advisor, will present research at the inaugural meeting of the American Society of Gene Therapy that shows the ability of AAV-mediated gene therapy to achieve sustained production of factor IX resulting in improved blood clotting times in a large animal model of hemophilia B.

"These results are very exciting, and can validate that AAV vectors in this model can provide sustained and long-term expression--something that other gene therapy systems have had limited success demonstrating," said John Monahan, Ph.D., president and chief executive officer of Avigen, Inc. "Based on these results and additional R&D advances at Avigen, we are working closely with Dr. High to develop this therapy further with the objective of initiating a human clinical trial as early as the end of calendar 1998 which, if successful, will represent a major advance in the treatment of hemophilia B."

"Our work extends previous results obtained in mice to a well-defined, naturally occurring, large animal model of hemophilia B that is very similar to the disease in humans," commented Dr. High. "This is the first example of the intramuscular administration of a gene therapy vector resulting in sustained improvement of the clotting abnormality in hemophilia and is an important step in justifying this approach for the treatment of patients with hemophilia B."

A single intramuscular administration of an AAV vector containing the gene for factor IX was given. The animals showe

Contact: Joan Kureczka
Kureczka/Martin Associates

Page: 1 2 3

Related biology news :

1. 1st International Conference on Cell Therapy for Cardiovascular Disease
2. National Cancer Gene Therapy Foundation gives $4.0 million in research grants
3. Braunschweig Prize 2003 for Molecular Cancer Therapy
4. Alliance for Cancer Gene Therapy announces $1.5 million in national grants to young investigators
5. New research on safety of intracoronary delivery of adenovector reported in cover story of Molecular Therapy
6. Therapy hinders AIDS virus from evolving drug resistance, Hopkins researchers find
7. Invitation To Cover: American Society Of Gene Therapy Meeting
8. Gene Therapy For Pain
9. Role Of Protein Linked To Colon Cancer Identified, Offering Potential Target For Therapy
10. Shock Therapy Exceeds Expectations In Cleaning Up Contaminated Soils
11. Penn Researchers Develop Gene Therapy Technique That Reverses Muscle Membrane Weakness In Muscular Dystrophy Variant

Post Your Comments:

(Date:7/28/2018)... ... July 28, 2018 , ... ... Kong Polytechnic University (PolyU), has been honoured with the International Association for Wind ... of wind engineering and bridge engineering in research, education, and application. Professor Xu ...
(Date:7/26/2018)... ... July 26, 2018 , ... Shirley Holmlund, an evidence-based ... biofield energy healing treated Vitamin D3 on the strength and health of bones. ... 290% improvement in bone mineralization and over 100% increase in ALP, a bone-specific ...
(Date:7/25/2018)... ... July 25, 2018 , ... A pioneering Duchenne muscular dystrophy clinical trial ... annual Mt. Kinabalu climb to raising awareness of the need to enroll patients. ... with patients and families willing to participate in a clinical trial,” said Catherine Jayasuriya, ...
Breaking Biology News(10 mins):
(Date:8/9/2018)... ... August 09, 2018 , ... Simpson Gumpertz & Heger (SGH) ... building owners and managers for a full-day discussion on health care and life ... Boston for the first time on Thursday, 13 September 2018, at Harvard Medical ...
(Date:8/7/2018)... ... 06, 2018 , ... PetPace , the makers of a smart health-monitoring ... announced the launch of a groundbreaking study to identify and eventually predict problems and ... of pregnant dogs sponsored by PetPace and conducted by Dr. Smadar Tal, DVM, DACT, ...
(Date:7/31/2018)... ... July 31, 2018 , ... Leading regenerative ... methods for extracting and using adipose tissue-derived stem cells to treat or prevent ... While this patent covers Canada specifically, VetStem has been issued similar patents that ...
(Date:7/31/2018)... ... 31, 2018 , ... Mahoney Environmental , a leading ... new website. The new website has been designed with improved functionality and navigation, ... Innovative to build a website created for the customer. The newly redesigned site ...
Breaking Biology Technology:
Cached News: